SCHEMBL2455796

SCHEMBL2455796

O=C(O)C1C[CH]CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663681 1.00
SCHEMBL1661673 1.00
SCHEMBL15330936 0.78
SCHEMBL3200924 0.78
SCHEMBL5010024 0.78
SCHEMBL1476768 0.78
SCHEMBL6597668 0.78
SCHEMBL18576616 0.78
Hydrochloric Acid SCHEMBL9143086 0.76 EGLN1 (0.45)
SCHEMBL27558661 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 US claimed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 WO claimed
WO-2016133832-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-25 WO claimed
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 WO claimed
EP-2632255-A1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES Merck Sharp & Dohme Corp. (US) 2013-09-04 EP claimed
WO-2012058203-A1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO claimed
US-20110257181-A1 PYRIDAZINONE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-10-20 US claimed
EP-2367815-A1 PYRIDAZINONE DERIVATIVES Merck Patent GmbH (DE) 2011-09-28 EP claimed
WO-2010072296-A1 PYRIDAZINONE DERIVATIVES MERCK PATENT GMBH (DE) 2010-07-01 WO claimed
US-6756400-B2 Sodium channel modulators THERAVANCE, INC. 2004-06-29 US claimed
CN-1059336-A Anti-fungal triazole derivatives and preparation thereof and purposes SANKYO CO (JP) 1992-03-11 CN claimed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP claimed
US-20240150362-A1 Substituted Pyrrolotriazines MOLECURE S.A. (PL) 2024-05-09 US disclosed
WO-2024042494-A1 SUBSTITUTED PYRROLOTRIAZINES MOLECURE SA (PL) 2024-02-29 WO disclosed
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 WO disclosed
EP-2367815-B1 PYRIDAZINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-01-14 EP disclosed
US-5393769-A Thio-, sulfinyl- or sulfonyl-substituted SANKYO COMPANY, LIMITED (JP) 1995-02-28 US disclosed
CN-1026786-C Anti-fungal triazole derivatives, their preparation and uses SANKYO CO (JP) 1994-11-30 CN disclosed
CN-1059336-A Anti-fungal triazole derivatives and preparation thereof and purposes SANKYO CO (JP) 1992-03-11 CN disclosed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP disclosed